TOMSICEK MICHAEL JOHN
SEC insider (Form 3/4/5 filer). CIK 0001570392. Director at Acrivon Therapeutics, Inc. (ACRV) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on Jun 17, 2026. Located in MONTREAL.
Companies TOMSICEK MICHAEL JOHN has filed insider reports for
- Acrivon Therapeutics, Inc. (ACRV): Director
- Milestone Pharmaceuticals Inc. (MIST): Director
TOMSICEK MICHAEL JOHN
CIK: 0001570392
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jun 17, 2026ACRV
Acrivon Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
20.3K shares- - Jun 10, 2026MIST
Milestone Pharmaceuticals Inc.
AwardDirectStock Option (right to buy)
77K shares- - May 18, 2026ACRV
Acrivon Therapeutics, Inc.
AwardDirect9.4K shares- - Jun 13, 2025ACRV
Acrivon Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
20.3K shares- - Jun 10, 2025MIST
Milestone Pharmaceuticals Inc.
AwardDirectStock Option (right to buy)
40K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 17, 2026 |  ACRV Acrivon Therapeutics, Inc. | Award Stock Option (Right to Buy) | 20,275 | - | - | Direct |
| Jun 10, 2026 |  MIST Milestone Pharmaceuticals Inc. | Award Stock Option (right to buy) | 77,000 | - | - | Direct |
| May 18, 2026 | ACRV Acrivon Therapeutics, Inc. | Award | 9,366 | - | $0 | Direct |
| Jun 13, 2025 | ACRV Acrivon Therapeutics, Inc. | Award Stock Option (Right to Buy) | 20,275 | - | - | Direct |
| Jun 10, 2025 | MIST Milestone Pharmaceuticals Inc. | Award Stock Option (right to buy) | 40,000 | - | - | Direct |
1-5 of 5 transactions